GENSCRIPT BIO (SEHK: 01548) has announced the grant of a total of 14.74 million restricted share units. The grant was made on June 4, 2026, to four directors, the company's rotating chief executive officer, a number of employees, and one service provider.
The award is conditional upon acceptance and is subject to the terms and conditions of the 2021 Restricted Share Unit Plan.